Dennis Roop
Concepts (809)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epidermis | 82 | 2022 | 148 | 8.850 |
Why?
| Keratins | 110 | 2016 | 176 | 7.020 |
Why?
| Skin Neoplasms | 55 | 2019 | 754 | 4.240 |
Why?
| Keratinocytes | 52 | 2022 | 215 | 4.230 |
Why?
| Membrane Proteins | 39 | 2022 | 1016 | 4.060 |
Why?
| Skin | 48 | 2020 | 653 | 3.320 |
Why?
| Trans-Activators | 26 | 2013 | 366 | 3.060 |
Why?
| Phosphoproteins | 17 | 2013 | 293 | 2.260 |
Why?
| Cell Differentiation | 73 | 2020 | 1696 | 2.250 |
Why?
| Papilloma | 31 | 2011 | 42 | 2.230 |
Why?
| Cell Transformation, Neoplastic | 25 | 2016 | 307 | 2.210 |
Why?
| NF-E2-Related Factor 2 | 7 | 2022 | 71 | 2.050 |
Why?
| Mice, Transgenic | 64 | 2017 | 1947 | 2.020 |
Why?
| Hyperkeratosis, Epidermolytic | 15 | 2008 | 20 | 2.010 |
Why?
| Mice | 181 | 2020 | 14847 | 1.960 |
Why?
| Stem Cells | 18 | 2017 | 541 | 1.880 |
Why?
| Animals | 223 | 2020 | 31570 | 1.640 |
Why?
| Genes, ras | 25 | 2012 | 91 | 1.630 |
Why?
| Hair Follicle | 14 | 2020 | 44 | 1.480 |
Why?
| Genetic Therapy | 12 | 2014 | 256 | 1.380 |
Why?
| Mutation | 35 | 2018 | 3338 | 1.220 |
Why?
| Point Mutation | 13 | 2009 | 216 | 1.170 |
Why?
| Skin Diseases | 8 | 2014 | 121 | 1.130 |
Why?
| Carcinoma, Squamous Cell | 20 | 2016 | 577 | 1.100 |
Why?
| Transforming Growth Factor alpha | 10 | 2000 | 53 | 0.990 |
Why?
| Ichthyosis | 7 | 2016 | 12 | 0.960 |
Why?
| Mice, Knockout | 32 | 2018 | 2563 | 0.960 |
Why?
| Induced Pluripotent Stem Cells | 5 | 2018 | 182 | 0.960 |
Why?
| Cell Division | 19 | 2016 | 754 | 0.930 |
Why?
| Disease Models, Animal | 29 | 2020 | 3499 | 0.920 |
Why?
| Melanoma | 10 | 2020 | 620 | 0.920 |
Why?
| Gene Expression Regulation | 30 | 2016 | 2322 | 0.910 |
Why?
| Phenotype | 26 | 2021 | 2784 | 0.910 |
Why?
| Ectodermal Dysplasia | 5 | 2009 | 15 | 0.900 |
Why?
| DNA-Binding Proteins | 15 | 2015 | 1311 | 0.900 |
Why?
| Morphogenesis | 7 | 2010 | 159 | 0.880 |
Why?
| Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 10 | 0.880 |
Why?
| Vitiligo | 6 | 2020 | 41 | 0.860 |
Why?
| Base Sequence | 48 | 2016 | 2114 | 0.860 |
Why?
| Gene Expression Regulation, Developmental | 13 | 2015 | 801 | 0.840 |
Why?
| Genes, fos | 10 | 2000 | 33 | 0.840 |
Why?
| Neoplasms, Experimental | 4 | 2019 | 149 | 0.830 |
Why?
| Ultraviolet Rays | 8 | 2018 | 363 | 0.820 |
Why?
| Transgenes | 13 | 2016 | 170 | 0.820 |
Why?
| Genes, p53 | 10 | 2012 | 61 | 0.810 |
Why?
| Gene Expression Regulation, Neoplastic | 18 | 2015 | 1144 | 0.810 |
Why?
| Tetradecanoylphorbol Acetate | 21 | 2010 | 151 | 0.800 |
Why?
| Tumor Suppressor Proteins | 8 | 2009 | 283 | 0.800 |
Why?
| Tumor Suppressor Protein p53 | 6 | 2011 | 445 | 0.790 |
Why?
| Collagen Type VII | 1 | 2021 | 13 | 0.760 |
Why?
| Jews | 1 | 2021 | 18 | 0.760 |
Why?
| Epidermolysis Bullosa Dystrophica | 1 | 2021 | 21 | 0.750 |
Why?
| Intermediate Filament Proteins | 22 | 2012 | 65 | 0.750 |
Why?
| Skin Physiological Phenomena | 7 | 2008 | 26 | 0.740 |
Why?
| Melanocytes | 6 | 2020 | 55 | 0.740 |
Why?
| Neoplastic Stem Cells | 7 | 2016 | 327 | 0.720 |
Why?
| Cells, Cultured | 37 | 2020 | 3862 | 0.710 |
Why?
| Cell Lineage | 5 | 2010 | 308 | 0.690 |
Why?
| Transcription Factors | 16 | 2015 | 1526 | 0.670 |
Why?
| Ichthyosis, Lamellar | 2 | 2016 | 9 | 0.660 |
Why?
| Intravital Microscopy | 1 | 2019 | 23 | 0.650 |
Why?
| Cytoskeletal Proteins | 9 | 2012 | 145 | 0.650 |
Why?
| Genes, myc | 4 | 2011 | 46 | 0.640 |
Why?
| Proto-Oncogene Proteins c-myc | 5 | 2010 | 116 | 0.630 |
Why?
| Signal Transduction | 22 | 2020 | 4501 | 0.630 |
Why?
| Pluripotent Stem Cells | 2 | 2010 | 64 | 0.600 |
Why?
| Molecular Sequence Data | 33 | 2012 | 2783 | 0.600 |
Why?
| Hair | 6 | 2012 | 65 | 0.600 |
Why?
| Hedgehog Proteins | 7 | 2017 | 172 | 0.590 |
Why?
| Immunity, Cellular | 1 | 2019 | 247 | 0.580 |
Why?
| Genes | 15 | 2008 | 223 | 0.580 |
Why?
| Skin Diseases, Genetic | 6 | 2020 | 10 | 0.570 |
Why?
| Keratin-6 | 5 | 2016 | 6 | 0.550 |
Why?
| Head and Neck Neoplasms | 5 | 2016 | 427 | 0.540 |
Why?
| Protein Isoforms | 8 | 2008 | 337 | 0.530 |
Why?
| Humans | 125 | 2021 | 114080 | 0.520 |
Why?
| Amino Acid Sequence | 30 | 2012 | 1981 | 0.520 |
Why?
| Multipotent Stem Cells | 3 | 2010 | 17 | 0.520 |
Why?
| Promoter Regions, Genetic | 16 | 2016 | 1131 | 0.510 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2016 | 122 | 0.500 |
Why?
| Viral Proteins | 4 | 2002 | 281 | 0.500 |
Why?
| Transforming Growth Factor beta | 8 | 2009 | 445 | 0.500 |
Why?
| Keratoderma, Palmoplantar | 3 | 2014 | 5 | 0.490 |
Why?
| Pachyonychia Congenita | 3 | 2014 | 4 | 0.480 |
Why?
| Genetic Vectors | 7 | 2013 | 287 | 0.480 |
Why?
| Cell Proliferation | 13 | 2016 | 2173 | 0.480 |
Why?
| Tretinoin | 11 | 2014 | 122 | 0.470 |
Why?
| Animals, Newborn | 23 | 2007 | 777 | 0.470 |
Why?
| Cadherins | 3 | 2016 | 175 | 0.460 |
Why?
| Epithelium | 14 | 2004 | 295 | 0.460 |
Why?
| Mice, Mutant Strains | 12 | 2016 | 271 | 0.460 |
Why?
| Keratosis | 7 | 2000 | 13 | 0.460 |
Why?
| Cell Culture Techniques | 3 | 2014 | 341 | 0.460 |
Why?
| DNA | 24 | 2018 | 1350 | 0.460 |
Why?
| Cell Cycle | 3 | 2012 | 541 | 0.450 |
Why?
| Proteomics | 2 | 2016 | 815 | 0.440 |
Why?
| Ultraviolet Therapy | 3 | 2020 | 16 | 0.440 |
Why?
| Amniotic Fluid | 2 | 2012 | 64 | 0.440 |
Why?
| Mice, Inbred ICR | 10 | 2011 | 108 | 0.440 |
Why?
| Genes, Dominant | 6 | 2016 | 93 | 0.440 |
Why?
| Gene Deletion | 7 | 2012 | 356 | 0.420 |
Why?
| Up-Regulation | 8 | 2020 | 802 | 0.420 |
Why?
| Transcription, Genetic | 23 | 2017 | 1310 | 0.420 |
Why?
| Nails, Malformed | 2 | 2005 | 5 | 0.420 |
Why?
| Carcinoma, Basal Cell | 2 | 2017 | 66 | 0.410 |
Why?
| Abnormalities, Multiple | 3 | 2014 | 176 | 0.410 |
Why?
| Eyelids | 2 | 2009 | 27 | 0.410 |
Why?
| Cleft Lip | 2 | 2009 | 31 | 0.410 |
Why?
| Transforming Growth Factor beta2 | 1 | 2012 | 31 | 0.400 |
Why?
| Melanoma, Experimental | 3 | 1998 | 89 | 0.400 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2012 | 367 | 0.400 |
Why?
| Cleft Palate | 2 | 2009 | 49 | 0.400 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 16 | 2010 | 22 | 0.390 |
Why?
| Mutation, Missense | 3 | 2016 | 294 | 0.390 |
Why?
| DNA Primers | 12 | 2010 | 508 | 0.380 |
Why?
| Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.380 |
Why?
| Carcinogens | 11 | 2010 | 102 | 0.380 |
Why?
| Mosaicism | 4 | 2014 | 62 | 0.380 |
Why?
| Calcium | 12 | 2010 | 1089 | 0.380 |
Why?
| Apoptosis | 9 | 2012 | 2349 | 0.370 |
Why?
| Wnt Signaling Pathway | 1 | 2012 | 146 | 0.370 |
Why?
| Proteins | 3 | 2016 | 906 | 0.360 |
Why?
| RNA, Messenger | 35 | 2016 | 2550 | 0.360 |
Why?
| Centrosome | 4 | 2012 | 59 | 0.360 |
Why?
| Pedigree | 11 | 2000 | 460 | 0.360 |
Why?
| Keratin-10 | 7 | 2016 | 7 | 0.350 |
Why?
| Alleles | 7 | 2016 | 789 | 0.350 |
Why?
| Immunotherapy | 3 | 2020 | 473 | 0.340 |
Why?
| Integrases | 5 | 2004 | 116 | 0.340 |
Why?
| Stem Cell Niche | 1 | 2010 | 41 | 0.340 |
Why?
| Female | 71 | 2021 | 59349 | 0.340 |
Why?
| Gene Targeting | 5 | 2008 | 75 | 0.330 |
Why?
| Transcription Factor AP-2 | 2 | 2008 | 81 | 0.320 |
Why?
| Genes, Recessive | 2 | 2021 | 74 | 0.320 |
Why?
| Wound Healing | 4 | 2010 | 254 | 0.320 |
Why?
| Skin Pigmentation | 2 | 2020 | 39 | 0.320 |
Why?
| Polymerase Chain Reaction | 12 | 2000 | 990 | 0.300 |
Why?
| Disease Progression | 6 | 2019 | 2371 | 0.300 |
Why?
| Lipid Metabolism | 5 | 2018 | 441 | 0.290 |
Why?
| Mice, Inbred Strains | 13 | 2010 | 398 | 0.290 |
Why?
| Keratins, Type II | 1 | 2007 | 2 | 0.290 |
Why?
| Adenoviridae | 3 | 1998 | 184 | 0.290 |
Why?
| Fluorescent Antibody Technique | 19 | 2004 | 396 | 0.280 |
Why?
| Epidermolysis Bullosa Simplex | 3 | 2004 | 9 | 0.280 |
Why?
| Aurora Kinases | 3 | 2012 | 28 | 0.280 |
Why?
| Octamer Transcription Factor-3 | 1 | 2007 | 16 | 0.280 |
Why?
| Mice, Nude | 11 | 2016 | 628 | 0.280 |
Why?
| Aurora Kinase A | 3 | 2012 | 51 | 0.280 |
Why?
| Mice, Inbred BALB C | 17 | 2020 | 1144 | 0.270 |
Why?
| Transcription Factor AP-1 | 3 | 2014 | 81 | 0.270 |
Why?
| Amino Acid Substitution | 4 | 2000 | 261 | 0.270 |
Why?
| Mice, Inbred C57BL | 18 | 2015 | 4682 | 0.270 |
Why?
| Models, Biological | 8 | 2016 | 1611 | 0.270 |
Why?
| Male | 47 | 2021 | 55420 | 0.260 |
Why?
| Proto-Oncogenes | 1 | 2006 | 26 | 0.260 |
Why?
| Homeostasis | 3 | 2020 | 570 | 0.260 |
Why?
| Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 5 | 0.260 |
Why?
| Genes, Reporter | 4 | 2009 | 256 | 0.260 |
Why?
| Genomic Instability | 4 | 2011 | 38 | 0.260 |
Why?
| Lipids | 4 | 2018 | 564 | 0.260 |
Why?
| Hyperplasia | 9 | 1999 | 163 | 0.260 |
Why?
| Cell Line | 14 | 2018 | 2629 | 0.250 |
Why?
| Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 8 | 0.250 |
Why?
| Oncogene Protein p21(ras) | 4 | 2004 | 16 | 0.250 |
Why?
| Gene Expression | 12 | 2015 | 1417 | 0.240 |
Why?
| Mouth Neoplasms | 2 | 2004 | 70 | 0.240 |
Why?
| Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 228 | 0.240 |
Why?
| Keratin-1 | 2 | 2016 | 2 | 0.240 |
Why?
| Skin Diseases, Vesiculobullous | 2 | 1999 | 17 | 0.240 |
Why?
| Intermediate Filaments | 6 | 2015 | 46 | 0.240 |
Why?
| Prenatal Diagnosis | 2 | 1998 | 163 | 0.240 |
Why?
| ras Proteins | 4 | 2013 | 138 | 0.230 |
Why?
| beta Catenin | 3 | 2020 | 218 | 0.230 |
Why?
| Protein Precursors | 9 | 2006 | 119 | 0.230 |
Why?
| Retinoids | 2 | 1997 | 31 | 0.230 |
Why?
| Heterozygote | 4 | 2010 | 250 | 0.220 |
Why?
| Sequence Analysis, DNA | 6 | 2016 | 722 | 0.220 |
Why?
| Mifepristone | 8 | 2009 | 60 | 0.220 |
Why?
| Cocarcinogenesis | 4 | 2000 | 14 | 0.220 |
Why?
| Transfection | 10 | 2017 | 863 | 0.210 |
Why?
| Lac Operon | 2 | 2000 | 44 | 0.210 |
Why?
| Transduction, Genetic | 4 | 2009 | 113 | 0.210 |
Why?
| Skin Transplantation | 5 | 2016 | 57 | 0.210 |
Why?
| Antioxidants | 2 | 2020 | 529 | 0.210 |
Why?
| Proto-Oncogene Proteins | 5 | 2013 | 607 | 0.210 |
Why?
| Oncogenes | 5 | 1994 | 104 | 0.210 |
Why?
| Cilia | 2 | 2017 | 162 | 0.210 |
Why?
| Cytoskeleton | 8 | 1994 | 176 | 0.200 |
Why?
| Gene Transfer Techniques | 3 | 2000 | 147 | 0.200 |
Why?
| Wnt Proteins | 3 | 2010 | 134 | 0.200 |
Why?
| Cell Membrane | 7 | 2015 | 670 | 0.200 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 924 | 0.200 |
Why?
| Alopecia | 4 | 2005 | 28 | 0.200 |
Why?
| Hindlimb | 2 | 1999 | 130 | 0.200 |
Why?
| Chromosome Mapping | 5 | 2016 | 486 | 0.190 |
Why?
| Chile | 1 | 2021 | 16 | 0.190 |
Why?
| Colombia | 1 | 2021 | 34 | 0.190 |
Why?
| Permeability | 3 | 2016 | 149 | 0.190 |
Why?
| I-kappa B Kinase | 4 | 2009 | 50 | 0.190 |
Why?
| RNA | 6 | 2018 | 806 | 0.180 |
Why?
| Mexico | 1 | 2021 | 162 | 0.180 |
Why?
| Molecular Imprinting | 1 | 2020 | 4 | 0.180 |
Why?
| Carcinoma | 5 | 1995 | 198 | 0.180 |
Why?
| Epithelial Cells | 13 | 2006 | 946 | 0.180 |
Why?
| Neoplasm Transplantation | 6 | 2016 | 227 | 0.180 |
Why?
| Keratin-14 | 4 | 2012 | 12 | 0.180 |
Why?
| Ceramides | 3 | 2016 | 91 | 0.180 |
Why?
| Antineoplastic Agents | 5 | 2016 | 1875 | 0.170 |
Why?
| Regenerative Medicine | 2 | 2019 | 41 | 0.170 |
Why?
| Adult Stem Cells | 1 | 2020 | 32 | 0.170 |
Why?
| Laser Capture Microdissection | 2 | 2017 | 23 | 0.170 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 270 | 0.170 |
Why?
| Zebrafish Proteins | 1 | 2002 | 248 | 0.170 |
Why?
| Blotting, Western | 8 | 2007 | 1143 | 0.170 |
Why?
| Papillomaviridae | 3 | 2016 | 101 | 0.170 |
Why?
| Cell Membrane Permeability | 1 | 2020 | 83 | 0.170 |
Why?
| Molecular Weight | 15 | 1990 | 328 | 0.170 |
Why?
| Precancerous Conditions | 4 | 2004 | 155 | 0.170 |
Why?
| Immunologic Surveillance | 1 | 2019 | 19 | 0.170 |
Why?
| Bimatoprost | 1 | 2019 | 3 | 0.160 |
Why?
| Arginine | 2 | 2007 | 236 | 0.160 |
Why?
| Genetic Linkage | 4 | 1999 | 294 | 0.160 |
Why?
| Guided Tissue Regeneration | 1 | 2019 | 13 | 0.160 |
Why?
| Janus Kinase Inhibitors | 1 | 2019 | 10 | 0.160 |
Why?
| Alopecia Areata | 1 | 2019 | 9 | 0.160 |
Why?
| Crosses, Genetic | 4 | 2010 | 136 | 0.160 |
Why?
| Tongue | 1 | 1999 | 67 | 0.160 |
Why?
| Skin Aging | 2 | 1997 | 19 | 0.160 |
Why?
| Cloning, Molecular | 8 | 2000 | 522 | 0.160 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2020 | 695 | 0.160 |
Why?
| Threonine | 1 | 1999 | 40 | 0.160 |
Why?
| Deafness | 1 | 2000 | 77 | 0.160 |
Why?
| Asparagine | 1 | 1999 | 29 | 0.160 |
Why?
| Thymidine Kinase | 2 | 1998 | 14 | 0.160 |
Why?
| Zinc Finger Protein GLI1 | 2 | 2017 | 21 | 0.160 |
Why?
| Tumor Cells, Cultured | 7 | 2016 | 845 | 0.160 |
Why?
| Ovalbumin | 7 | 1981 | 161 | 0.160 |
Why?
| Caspase 14 | 1 | 2018 | 1 | 0.150 |
Why?
| Simplexvirus | 2 | 1998 | 80 | 0.150 |
Why?
| Microscopy, Immunoelectron | 4 | 2016 | 43 | 0.150 |
Why?
| Proto-Oncogene Proteins c-jun | 2 | 1999 | 47 | 0.150 |
Why?
| Cytoprotection | 1 | 2018 | 51 | 0.150 |
Why?
| Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.150 |
Why?
| Transplantation, Heterologous | 3 | 2011 | 180 | 0.150 |
Why?
| Gene Silencing | 2 | 2016 | 171 | 0.140 |
Why?
| Microscopy, Electron | 9 | 2002 | 408 | 0.140 |
Why?
| Caspase 3 | 2 | 2010 | 234 | 0.140 |
Why?
| Mammary Glands, Animal | 2 | 2006 | 117 | 0.140 |
Why?
| Potoroidae | 2 | 2007 | 3 | 0.140 |
Why?
| Oncogene Proteins, Viral | 2 | 1994 | 19 | 0.140 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 211 | 0.140 |
Why?
| Desmosomes | 2 | 2016 | 20 | 0.140 |
Why?
| Protein Multimerization | 1 | 2018 | 157 | 0.140 |
Why?
| Receptors, Retinoic Acid | 1 | 1997 | 49 | 0.140 |
Why?
| Syndrome | 3 | 2009 | 330 | 0.140 |
Why?
| Exons | 2 | 2016 | 301 | 0.140 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 1997 | 52 | 0.140 |
Why?
| Fibroblasts | 5 | 2018 | 836 | 0.140 |
Why?
| Dermatitis, Atopic | 1 | 2020 | 307 | 0.140 |
Why?
| Neovascularization, Pathologic | 1 | 1998 | 280 | 0.140 |
Why?
| Mutagenesis, Site-Directed | 4 | 1999 | 345 | 0.140 |
Why?
| Nucleic Acid Hybridization | 13 | 1991 | 187 | 0.130 |
Why?
| Glucosylceramides | 1 | 2016 | 7 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| Kallikreins | 1 | 2016 | 28 | 0.130 |
Why?
| Recombinant Fusion Proteins | 2 | 1996 | 613 | 0.130 |
Why?
| Bone Morphogenetic Protein 4 | 2 | 2014 | 34 | 0.130 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 333 | 0.130 |
Why?
| Epithelial-Mesenchymal Transition | 3 | 2013 | 167 | 0.130 |
Why?
| Gene Amplification | 2 | 2011 | 95 | 0.130 |
Why?
| SOXB1 Transcription Factors | 1 | 2016 | 60 | 0.130 |
Why?
| Side-Population Cells | 2 | 2013 | 9 | 0.130 |
Why?
| Aldehyde Dehydrogenase | 2 | 2016 | 102 | 0.130 |
Why?
| Microscopy, Fluorescence | 5 | 2007 | 393 | 0.130 |
Why?
| Amino Acid Motifs | 1 | 2016 | 197 | 0.130 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2016 | 129 | 0.130 |
Why?
| Genes, Regulator | 2 | 1993 | 34 | 0.130 |
Why?
| Hematopoietic Stem Cells | 3 | 2015 | 338 | 0.120 |
Why?
| Cetuximab | 1 | 2015 | 90 | 0.120 |
Why?
| Hand Deformities, Congenital | 1 | 2014 | 8 | 0.120 |
Why?
| Trachea | 4 | 1993 | 223 | 0.120 |
Why?
| Chloracne | 1 | 2014 | 1 | 0.110 |
Why?
| Cricetinae | 9 | 1994 | 252 | 0.110 |
Why?
| Keratin-2 | 3 | 2000 | 3 | 0.110 |
Why?
| Nuclear Proteins | 3 | 2006 | 591 | 0.110 |
Why?
| RNA, Neoplasm | 6 | 1995 | 80 | 0.110 |
Why?
| Genes, Tumor Suppressor | 2 | 2004 | 77 | 0.110 |
Why?
| Dermis | 2 | 2010 | 30 | 0.110 |
Why?
| Transcriptional Activation | 4 | 2007 | 337 | 0.110 |
Why?
| Cellular Reprogramming | 1 | 2014 | 85 | 0.110 |
Why?
| Hearing Loss, Sensorineural | 1 | 2014 | 54 | 0.110 |
Why?
| Recombination, Genetic | 2 | 2008 | 176 | 0.110 |
Why?
| Vagina | 3 | 1994 | 146 | 0.110 |
Why?
| Hormones | 2 | 1994 | 132 | 0.110 |
Why?
| Embryonic and Fetal Development | 3 | 2002 | 94 | 0.110 |
Why?
| Genetic Engineering | 2 | 2007 | 80 | 0.110 |
Why?
| Smad4 Protein | 1 | 2013 | 34 | 0.110 |
Why?
| DNA Mutational Analysis | 3 | 2018 | 373 | 0.110 |
Why?
| Embryoid Bodies | 1 | 2013 | 7 | 0.110 |
Why?
| Fatty Acid Transport Proteins | 1 | 2012 | 18 | 0.100 |
Why?
| RNA Splice Sites | 1 | 2012 | 33 | 0.100 |
Why?
| Models, Animal | 4 | 2013 | 340 | 0.100 |
Why?
| DNA Restriction Enzymes | 7 | 1998 | 54 | 0.100 |
Why?
| Keratins, Hair-Specific | 1 | 2012 | 1 | 0.100 |
Why?
| Fetal Diseases | 1 | 1994 | 146 | 0.100 |
Why?
| Polyploidy | 1 | 2012 | 16 | 0.100 |
Why?
| Dermatology | 1 | 2014 | 86 | 0.100 |
Why?
| Polymorphism, Restriction Fragment Length | 3 | 2004 | 65 | 0.100 |
Why?
| Macromolecular Substances | 7 | 1992 | 200 | 0.100 |
Why?
| Cell Separation | 2 | 2007 | 290 | 0.100 |
Why?
| RNA, Small Interfering | 3 | 2012 | 534 | 0.100 |
Why?
| Carrier Proteins | 2 | 2003 | 694 | 0.100 |
Why?
| Binding Sites | 4 | 2006 | 1166 | 0.100 |
Why?
| Tumor Microenvironment | 1 | 2015 | 428 | 0.100 |
Why?
| MicroRNAs | 2 | 2015 | 600 | 0.100 |
Why?
| Immunohistochemistry | 14 | 2007 | 1624 | 0.100 |
Why?
| Cell Movement | 4 | 2019 | 863 | 0.100 |
Why?
| Cancer Vaccines | 3 | 1998 | 137 | 0.100 |
Why?
| Embryo, Mammalian | 3 | 2010 | 213 | 0.100 |
Why?
| Neoplasms | 2 | 2006 | 2089 | 0.090 |
Why?
| Cerebellar Ataxia | 1 | 2011 | 7 | 0.090 |
Why?
| Biomarkers, Tumor | 7 | 2009 | 1032 | 0.090 |
Why?
| Immunocompetence | 1 | 2011 | 40 | 0.090 |
Why?
| Carcinogenesis | 3 | 2021 | 175 | 0.090 |
Why?
| Drug Resistance, Neoplasm | 2 | 2012 | 637 | 0.090 |
Why?
| Epitopes | 3 | 1997 | 434 | 0.090 |
Why?
| Introns | 4 | 2004 | 227 | 0.090 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 1999 | 81 | 0.090 |
Why?
| Cell Count | 2 | 1991 | 303 | 0.090 |
Why?
| Integrins | 1 | 2011 | 80 | 0.090 |
Why?
| Sebaceous Glands | 1 | 2010 | 4 | 0.090 |
Why?
| Keratolytic Agents | 1 | 2010 | 5 | 0.090 |
Why?
| Ribosomal Proteins | 1 | 2011 | 70 | 0.090 |
Why?
| Proto-Oncogene Proteins c-fos | 3 | 1999 | 165 | 0.090 |
Why?
| Calcification, Physiologic | 1 | 2011 | 34 | 0.090 |
Why?
| Decidua | 1 | 2010 | 23 | 0.090 |
Why?
| Nevus | 1 | 2010 | 26 | 0.090 |
Why?
| Polymorphism, Genetic | 1 | 1993 | 610 | 0.090 |
Why?
| Neoplasm Recurrence, Local | 1 | 2015 | 850 | 0.090 |
Why?
| Genetic Techniques | 2 | 2005 | 57 | 0.090 |
Why?
| Adenocarcinoma, Sebaceous | 1 | 2010 | 1 | 0.090 |
Why?
| Sebaceous Gland Neoplasms | 1 | 2010 | 2 | 0.090 |
Why?
| Mitochondria | 1 | 2015 | 744 | 0.090 |
Why?
| Genotype | 4 | 2015 | 1757 | 0.090 |
Why?
| Aneuploidy | 2 | 2007 | 84 | 0.090 |
Why?
| Caspase 7 | 1 | 2010 | 20 | 0.090 |
Why?
| Osteoblasts | 1 | 2011 | 106 | 0.090 |
Why?
| In Situ Nick-End Labeling | 2 | 2007 | 119 | 0.090 |
Why?
| Liver Regeneration | 1 | 2010 | 29 | 0.090 |
Why?
| Organ Specificity | 4 | 2007 | 266 | 0.080 |
Why?
| Gene Expression Profiling | 4 | 2015 | 1519 | 0.080 |
Why?
| Teratoma | 1 | 2010 | 92 | 0.080 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2009 | 13 | 0.080 |
Why?
| Mammary Neoplasms, Experimental | 1 | 1990 | 64 | 0.080 |
Why?
| Reactive Oxygen Species | 1 | 2012 | 522 | 0.080 |
Why?
| Uterus | 1 | 2010 | 191 | 0.080 |
Why?
| Collagen | 2 | 1988 | 414 | 0.080 |
Why?
| Oviducts | 9 | 1982 | 15 | 0.080 |
Why?
| Selection, Genetic | 1 | 2011 | 237 | 0.080 |
Why?
| Adult | 10 | 2020 | 30395 | 0.080 |
Why?
| Down-Regulation | 4 | 2009 | 594 | 0.080 |
Why?
| Non-Fibrillar Collagens | 1 | 1988 | 1 | 0.080 |
Why?
| Muscle, Smooth | 1 | 1990 | 143 | 0.080 |
Why?
| Osteogenesis | 1 | 2011 | 181 | 0.080 |
Why?
| Bromodeoxyuridine | 2 | 1999 | 72 | 0.080 |
Why?
| Pemphigoid, Bullous | 1 | 1988 | 7 | 0.080 |
Why?
| Stress, Physiological | 1 | 2012 | 379 | 0.080 |
Why?
| Receptor, Notch1 | 2 | 2006 | 59 | 0.080 |
Why?
| Spindle Apparatus | 1 | 2009 | 87 | 0.080 |
Why?
| Gene Knockdown Techniques | 1 | 2009 | 300 | 0.080 |
Why?
| Foot | 1 | 2009 | 103 | 0.080 |
Why?
| Receptors, Progesterone | 2 | 2002 | 319 | 0.080 |
Why?
| beta-Galactosidase | 2 | 1999 | 62 | 0.080 |
Why?
| Cell Line, Tumor | 5 | 2015 | 2699 | 0.080 |
Why?
| Hand | 1 | 2009 | 135 | 0.080 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 107 | 0.070 |
Why?
| Genes, Lethal | 2 | 2008 | 26 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 388 | 0.070 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1356 | 0.070 |
Why?
| Cell Death | 1 | 2009 | 322 | 0.070 |
Why?
| Cytoplasmic Granules | 4 | 2002 | 81 | 0.070 |
Why?
| Hoof and Claw | 1 | 2007 | 5 | 0.070 |
Why?
| Protein Conformation | 6 | 1992 | 803 | 0.070 |
Why?
| Olfactory Mucosa | 1 | 2008 | 60 | 0.070 |
Why?
| Disease Susceptibility | 4 | 2006 | 316 | 0.070 |
Why?
| Protein Structure, Tertiary | 2 | 2007 | 796 | 0.070 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 140 | 0.070 |
Why?
| Langerhans Cells | 2 | 1997 | 11 | 0.070 |
Why?
| Growth Substances | 2 | 1999 | 138 | 0.070 |
Why?
| Caspase 9 | 1 | 2007 | 48 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2006 | 385 | 0.070 |
Why?
| Species Specificity | 3 | 2000 | 541 | 0.070 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1999 | 38 | 0.070 |
Why?
| Cell Adhesion | 3 | 2015 | 426 | 0.070 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 15 | 0.070 |
Why?
| Interleukin-1alpha | 2 | 2020 | 55 | 0.070 |
Why?
| Ganciclovir | 2 | 1998 | 48 | 0.070 |
Why?
| Glycine | 1 | 2007 | 152 | 0.070 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 66 | 0.070 |
Why?
| Lymphatic Metastasis | 1 | 2007 | 275 | 0.070 |
Why?
| Biological Assay | 1 | 2007 | 112 | 0.070 |
Why?
| Mice, SCID | 3 | 2013 | 312 | 0.070 |
Why?
| Twist-Related Protein 1 | 1 | 2006 | 10 | 0.070 |
Why?
| Blotting, Northern | 6 | 1992 | 193 | 0.070 |
Why?
| Phorbols | 1 | 1985 | 10 | 0.060 |
Why?
| Oxidative Stress | 1 | 2012 | 1068 | 0.060 |
Why?
| Antibodies | 2 | 1985 | 365 | 0.060 |
Why?
| Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| Autoantigens | 1 | 1988 | 396 | 0.060 |
Why?
| Models, Genetic | 3 | 2008 | 559 | 0.060 |
Why?
| Stomach | 2 | 2006 | 102 | 0.060 |
Why?
| Protein Structure, Secondary | 2 | 1999 | 325 | 0.060 |
Why?
| Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| Recombinant Proteins | 2 | 1999 | 1228 | 0.060 |
Why?
| Enzyme Activation | 1 | 2007 | 771 | 0.060 |
Why?
| United States | 1 | 2021 | 12144 | 0.060 |
Why?
| Cell Cycle Proteins | 2 | 2006 | 549 | 0.060 |
Why?
| Cyclins | 2 | 1996 | 78 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2006 | 167 | 0.060 |
Why?
| Pregnancy | 5 | 2010 | 5503 | 0.060 |
Why?
| Nerve Tissue Proteins | 1 | 1988 | 527 | 0.060 |
Why?
| Skin Abnormalities | 2 | 2002 | 10 | 0.060 |
Why?
| Sequence Analysis, RNA | 2 | 2017 | 388 | 0.060 |
Why?
| Embryonic Development | 1 | 2005 | 117 | 0.060 |
Why?
| Retinal Dehydrogenase | 2 | 2016 | 33 | 0.060 |
Why?
| Homeodomain Proteins | 2 | 2006 | 465 | 0.060 |
Why?
| RNA Interference | 3 | 2013 | 431 | 0.060 |
Why?
| Calcineurin | 1 | 2005 | 89 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 315 | 0.060 |
Why?
| Transglutaminases | 3 | 1995 | 142 | 0.060 |
Why?
| Biomarkers | 5 | 2004 | 3397 | 0.060 |
Why?
| Blotting, Southern | 3 | 2001 | 68 | 0.060 |
Why?
| Time Factors | 5 | 2004 | 6077 | 0.060 |
Why?
| In Vitro Techniques | 4 | 2013 | 1003 | 0.060 |
Why?
| Receptors, Cell Surface | 2 | 2005 | 350 | 0.060 |
Why?
| Tissue Distribution | 2 | 2002 | 285 | 0.050 |
Why?
| Flow Cytometry | 1 | 2007 | 1075 | 0.050 |
Why?
| Vimentin | 4 | 1994 | 58 | 0.050 |
Why?
| Molecular Structure | 2 | 1994 | 434 | 0.050 |
Why?
| Genetic Variation | 2 | 1998 | 868 | 0.050 |
Why?
| Dacarbazine | 2 | 2012 | 99 | 0.050 |
Why?
| S100 Proteins | 2 | 2000 | 37 | 0.050 |
Why?
| Keratin-15 | 1 | 2002 | 12 | 0.050 |
Why?
| Keratin-5 | 1 | 2002 | 46 | 0.050 |
Why?
| Mesocricetus | 5 | 1993 | 29 | 0.050 |
Why?
| Immunoenzyme Techniques | 4 | 1993 | 192 | 0.050 |
Why?
| 3T3 Cells | 3 | 2013 | 140 | 0.050 |
Why?
| Vitamin A Deficiency | 3 | 1993 | 27 | 0.050 |
Why?
| Bone and Bones | 1 | 2004 | 277 | 0.050 |
Why?
| Luteolytic Agents | 1 | 2001 | 1 | 0.050 |
Why?
| Autoantibodies | 1 | 1988 | 1350 | 0.050 |
Why?
| Administration, Topical | 3 | 1997 | 137 | 0.050 |
Why?
| Protein-Tyrosine Kinases | 1 | 2004 | 393 | 0.050 |
Why?
| Rats | 5 | 1994 | 4913 | 0.050 |
Why?
| Benzo(a)pyrene | 1 | 2000 | 7 | 0.050 |
Why?
| Zebrafish | 1 | 2004 | 413 | 0.050 |
Why?
| Response Elements | 2 | 2012 | 82 | 0.050 |
Why?
| Nuclear Localization Signals | 1 | 2000 | 14 | 0.040 |
Why?
| Frameshift Mutation | 1 | 2000 | 27 | 0.040 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 31 | 0.040 |
Why?
| Cell Survival | 3 | 2013 | 1014 | 0.040 |
Why?
| Kidney | 1 | 2007 | 1181 | 0.040 |
Why?
| Cell Compartmentation | 1 | 2000 | 51 | 0.040 |
Why?
| Netherton Syndrome | 1 | 2020 | 2 | 0.040 |
Why?
| Dermatitis, Exfoliative | 1 | 2020 | 4 | 0.040 |
Why?
| Repressor Proteins | 2 | 2013 | 367 | 0.040 |
Why?
| Cell Nucleus | 7 | 2004 | 552 | 0.040 |
Why?
| Adaptation, Biological | 1 | 2000 | 53 | 0.040 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2020 | 48 | 0.040 |
Why?
| Chickens | 9 | 1995 | 180 | 0.040 |
Why?
| Immunoblotting | 4 | 2003 | 282 | 0.040 |
Why?
| rho GTP-Binding Proteins | 1 | 2020 | 61 | 0.040 |
Why?
| Breast Neoplasms | 1 | 2011 | 1846 | 0.040 |
Why?
| DNA, Complementary | 2 | 2003 | 255 | 0.040 |
Why?
| Estrenes | 1 | 1999 | 15 | 0.040 |
Why?
| DNA, Neoplasm | 3 | 1995 | 155 | 0.040 |
Why?
| DNA Damage | 2 | 2012 | 351 | 0.040 |
Why?
| Phototherapy | 1 | 2019 | 24 | 0.040 |
Why?
| Genomic Library | 1 | 1999 | 15 | 0.040 |
Why?
| Restriction Mapping | 1 | 1999 | 77 | 0.040 |
Why?
| Genetic Carrier Screening | 1 | 1999 | 24 | 0.040 |
Why?
| Forelimb | 1 | 1999 | 24 | 0.040 |
Why?
| Peptides | 1 | 1984 | 847 | 0.040 |
Why?
| Protein Transport | 1 | 2000 | 391 | 0.040 |
Why?
| Cell Self Renewal | 1 | 2019 | 49 | 0.040 |
Why?
| Reference Values | 3 | 2002 | 739 | 0.040 |
Why?
| RNA, Heterogeneous Nuclear | 1 | 1978 | 4 | 0.040 |
Why?
| Sequence Analysis | 1 | 1998 | 35 | 0.040 |
Why?
| Fungal Proteins | 1 | 1999 | 119 | 0.040 |
Why?
| Thrombospondin 1 | 1 | 1998 | 19 | 0.040 |
Why?
| Dimerization | 1 | 1999 | 176 | 0.040 |
Why?
| Vascular Endothelial Growth Factors | 1 | 1998 | 61 | 0.040 |
Why?
| Endothelial Growth Factors | 1 | 1998 | 49 | 0.040 |
Why?
| Lymphokines | 1 | 1998 | 110 | 0.040 |
Why?
| Antigens, Neoplasm | 2 | 1997 | 222 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 742 | 0.040 |
Why?
| Body Patterning | 1 | 1999 | 127 | 0.040 |
Why?
| Mutagenesis, Insertional | 1 | 1998 | 61 | 0.040 |
Why?
| Protein Binding | 3 | 2009 | 1888 | 0.040 |
Why?
| Genes, bcl-2 | 1 | 1998 | 20 | 0.040 |
Why?
| Psoriasis | 2 | 1996 | 80 | 0.040 |
Why?
| Age of Onset | 1 | 1999 | 444 | 0.040 |
Why?
| Neovascularization, Physiologic | 1 | 1999 | 174 | 0.040 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 2090 | 0.040 |
Why?
| Biomechanical Phenomena | 1 | 2000 | 669 | 0.040 |
Why?
| Gamma Rays | 1 | 1998 | 47 | 0.040 |
Why?
| Retinoic Acid Receptor alpha | 1 | 1997 | 11 | 0.040 |
Why?
| Thymus Gland | 1 | 1998 | 296 | 0.040 |
Why?
| Epidermal Growth Factor | 3 | 1993 | 160 | 0.040 |
Why?
| Oxazines | 1 | 1997 | 25 | 0.040 |
Why?
| Retinoid X Receptors | 1 | 1997 | 39 | 0.040 |
Why?
| Mitotic Index | 1 | 1997 | 26 | 0.040 |
Why?
| Metaplasia | 3 | 1993 | 54 | 0.030 |
Why?
| Receptors, Calcitriol | 1 | 1997 | 53 | 0.030 |
Why?
| Clinical Trials, Phase II as Topic | 1 | 1997 | 59 | 0.030 |
Why?
| Interleukin-2 | 1 | 1998 | 413 | 0.030 |
Why?
| Hypertrophy | 1 | 1997 | 110 | 0.030 |
Why?
| Clinical Trials, Phase I as Topic | 1 | 1997 | 45 | 0.030 |
Why?
| Carcinogenicity Tests | 2 | 1994 | 5 | 0.030 |
Why?
| Luciferases | 2 | 2009 | 142 | 0.030 |
Why?
| Hybrid Cells | 2 | 1994 | 49 | 0.030 |
Why?
| Body Temperature | 1 | 1997 | 208 | 0.030 |
Why?
| Organ Culture Techniques | 4 | 1990 | 140 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1987 | 104 | 0.030 |
Why?
| Hyaluronan Receptors | 1 | 2016 | 90 | 0.030 |
Why?
| Extremities | 1 | 1997 | 111 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 1998 | 521 | 0.030 |
Why?
| Spheroids, Cellular | 1 | 2016 | 56 | 0.030 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 111 | 0.030 |
Why?
| Rats, Inbred F344 | 2 | 1993 | 241 | 0.030 |
Why?
| Middle Aged | 5 | 2020 | 26621 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 1998 | 496 | 0.030 |
Why?
| Kinetics | 5 | 1994 | 1547 | 0.030 |
Why?
| Rabbits | 2 | 1996 | 733 | 0.030 |
Why?
| Phospholipids | 1 | 1997 | 194 | 0.030 |
Why?
| Biopsy | 2 | 1997 | 1024 | 0.030 |
Why?
| Maximum Tolerated Dose | 1 | 2015 | 183 | 0.030 |
Why?
| Fluorescent Dyes | 1 | 1997 | 298 | 0.030 |
Why?
| PAX3 Transcription Factor | 1 | 2015 | 11 | 0.030 |
Why?
| Paired Box Transcription Factors | 1 | 2015 | 36 | 0.030 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1995 | 152 | 0.030 |
Why?
| Inhibins | 1 | 1995 | 45 | 0.030 |
Why?
| Interleukins | 1 | 1997 | 236 | 0.030 |
Why?
| Random Allocation | 1 | 2016 | 328 | 0.030 |
Why?
| Intramolecular Oxidoreductases | 1 | 2015 | 57 | 0.030 |
Why?
| Lung Neoplasms | 1 | 2007 | 2159 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 1998 | 1117 | 0.030 |
Why?
| Benzoates | 1 | 1995 | 38 | 0.030 |
Why?
| Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2015 | 63 | 0.030 |
Why?
| Immunity, Innate | 1 | 2020 | 720 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 314 | 0.030 |
Why?
| Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| Tetrahydronaphthalenes | 1 | 1995 | 29 | 0.030 |
Why?
| Treatment Outcome | 2 | 2020 | 9051 | 0.030 |
Why?
| DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| Evaluation Studies as Topic | 1 | 1994 | 167 | 0.030 |
Why?
| Infant, Newborn | 2 | 2009 | 5039 | 0.030 |
Why?
| Sequence Alignment | 1 | 1995 | 323 | 0.030 |
Why?
| Staining and Labeling | 2 | 2010 | 134 | 0.030 |
Why?
| Actin Cytoskeleton | 1 | 1995 | 93 | 0.030 |
Why?
| Ornithine Decarboxylase | 1 | 1994 | 9 | 0.030 |
Why?
| Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2015 | 618 | 0.030 |
Why?
| Antigens, CD | 1 | 2016 | 440 | 0.030 |
Why?
| Open Reading Frames | 1 | 1994 | 117 | 0.030 |
Why?
| Chorionic Villi | 1 | 1994 | 16 | 0.030 |
Why?
| Child | 3 | 2020 | 18408 | 0.030 |
Why?
| Protein Biosynthesis | 6 | 1991 | 386 | 0.030 |
Why?
| Collagen Type IV | 1 | 2014 | 22 | 0.030 |
Why?
| Simian virus 40 | 1 | 1993 | 22 | 0.030 |
Why?
| TATA Box | 1 | 1993 | 22 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 359 | 0.030 |
Why?
| Ovariectomy | 1 | 1994 | 116 | 0.030 |
Why?
| Laminin | 1 | 1994 | 69 | 0.030 |
Why?
| Integrin beta1 | 1 | 2013 | 17 | 0.030 |
Why?
| alpha Catenin | 1 | 2013 | 13 | 0.030 |
Why?
| Cholecalciferol | 1 | 1994 | 47 | 0.030 |
Why?
| Bone Marrow | 1 | 2015 | 243 | 0.030 |
Why?
| Constriction, Pathologic | 1 | 2014 | 207 | 0.030 |
Why?
| Clone Cells | 2 | 2010 | 247 | 0.030 |
Why?
| Butylhydroxybutylnitrosamine | 1 | 1993 | 6 | 0.030 |
Why?
| Cell Dedifferentiation | 1 | 2013 | 28 | 0.030 |
Why?
| Multigene Family | 1 | 1994 | 190 | 0.030 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 42 | 0.030 |
Why?
| Viruses | 1 | 1994 | 94 | 0.030 |
Why?
| Mice, Inbred CBA | 1 | 2013 | 49 | 0.030 |
Why?
| Collagen Type I | 1 | 2014 | 108 | 0.030 |
Why?
| ErbB Receptors | 1 | 2016 | 554 | 0.030 |
Why?
| Glycoproteins | 1 | 1995 | 304 | 0.030 |
Why?
| Sulfur Radioisotopes | 2 | 1990 | 17 | 0.030 |
Why?
| DNA Probes | 2 | 1992 | 59 | 0.030 |
Why?
| Sequence Deletion | 1 | 2013 | 166 | 0.030 |
Why?
| Forecasting | 1 | 1994 | 331 | 0.030 |
Why?
| Breast | 1 | 1993 | 138 | 0.030 |
Why?
| Chromosomes, Mammalian | 1 | 2012 | 25 | 0.030 |
Why?
| Lentivirus | 1 | 2013 | 45 | 0.030 |
Why?
| Diseases in Twins | 1 | 1994 | 174 | 0.030 |
Why?
| Serine | 1 | 1993 | 125 | 0.030 |
Why?
| Aldehyde Oxidoreductases | 1 | 2012 | 29 | 0.030 |
Why?
| Egg Proteins | 3 | 1982 | 19 | 0.030 |
Why?
| Proteome | 1 | 2015 | 337 | 0.020 |
Why?
| Bacteriophage lambda | 1 | 1993 | 81 | 0.020 |
Why?
| Cysteine | 1 | 1993 | 171 | 0.020 |
Why?
| Infant | 2 | 2009 | 7946 | 0.020 |
Why?
| Coloring Agents | 1 | 2012 | 72 | 0.020 |
Why?
| Limb Buds | 2 | 2004 | 20 | 0.020 |
Why?
| Age Factors | 2 | 1996 | 2886 | 0.020 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1997 | 687 | 0.020 |
Why?
| Biological Evolution | 2 | 1985 | 406 | 0.020 |
Why?
| Isoenzymes | 1 | 2012 | 283 | 0.020 |
Why?
| Tritium | 3 | 1994 | 66 | 0.020 |
Why?
| Myoepithelioma | 1 | 1991 | 2 | 0.020 |
Why?
| Gene Knock-In Techniques | 1 | 2011 | 46 | 0.020 |
Why?
| Mutagenicity Tests | 1 | 2011 | 9 | 0.020 |
Why?
| Child, Preschool | 2 | 2009 | 9121 | 0.020 |
Why?
| Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1690 | 0.020 |
Why?
| Hyperpigmentation | 1 | 2011 | 11 | 0.020 |
Why?
| Ovomucin | 2 | 1982 | 3 | 0.020 |
Why?
| Interleukin-8 | 1 | 2012 | 229 | 0.020 |
Why?
| Progesterone | 2 | 2010 | 232 | 0.020 |
Why?
| Haploinsufficiency | 1 | 2011 | 42 | 0.020 |
Why?
| Integrin-Binding Sialoprotein | 1 | 2011 | 4 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1361 | 0.020 |
Why?
| Rodent Diseases | 1 | 1991 | 25 | 0.020 |
Why?
| Paclitaxel | 1 | 2012 | 190 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 721 | 0.020 |
Why?
| Cytokines | 2 | 2015 | 1824 | 0.020 |
Why?
| Moloney murine leukemia virus | 1 | 1991 | 11 | 0.020 |
Why?
| Osteocalcin | 1 | 2011 | 34 | 0.020 |
Why?
| T-Lymphocytes | 1 | 1998 | 1735 | 0.020 |
Why?
| Embryo Implantation | 1 | 2010 | 23 | 0.020 |
Why?
| Wnt4 Protein | 1 | 2010 | 17 | 0.020 |
Why?
| Growth Disorders | 1 | 2011 | 77 | 0.020 |
Why?
| Swine | 1 | 1993 | 687 | 0.020 |
Why?
| Immunosorbent Techniques | 2 | 1987 | 17 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2012 | 552 | 0.020 |
Why?
| Urinary Bladder Neoplasms | 1 | 1993 | 196 | 0.020 |
Why?
| Estrogens | 4 | 1982 | 312 | 0.020 |
Why?
| DNA Repair | 1 | 2012 | 184 | 0.020 |
Why?
| Mitosis | 1 | 2011 | 164 | 0.020 |
Why?
| Follow-Up Studies | 1 | 1999 | 4392 | 0.020 |
Why?
| Pigmentation | 1 | 2010 | 54 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 1994 | 1331 | 0.020 |
Why?
| Phospholipases A2 | 1 | 2010 | 73 | 0.020 |
Why?
| Animals, Wild | 1 | 1990 | 44 | 0.020 |
Why?
| Mouth Mucosa | 1 | 1990 | 79 | 0.020 |
Why?
| Amino Acids | 4 | 2002 | 445 | 0.020 |
Why?
| Adenoma, Pleomorphic | 1 | 1990 | 8 | 0.020 |
Why?
| Parotid Neoplasms | 1 | 1990 | 14 | 0.020 |
Why?
| Anemia | 1 | 2011 | 143 | 0.020 |
Why?
| Smad3 Protein | 1 | 2009 | 41 | 0.020 |
Why?
| Enzyme Induction | 1 | 2009 | 83 | 0.020 |
Why?
| Arachidonic Acid | 1 | 2010 | 112 | 0.020 |
Why?
| Mice, Inbred C3H | 1 | 1990 | 242 | 0.020 |
Why?
| Imidazoles | 1 | 2010 | 203 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2010 | 139 | 0.020 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 75 | 0.020 |
Why?
| Case-Control Studies | 1 | 2016 | 3007 | 0.020 |
Why?
| Cellular Senescence | 1 | 2010 | 151 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2009 | 128 | 0.020 |
Why?
| Dinoprostone | 1 | 2010 | 183 | 0.020 |
Why?
| Diethylstilbestrol | 2 | 1979 | 8 | 0.020 |
Why?
| Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| Lactation | 1 | 1990 | 149 | 0.020 |
Why?
| Cell Communication | 1 | 2010 | 277 | 0.020 |
Why?
| Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| Methionine | 1 | 1989 | 144 | 0.020 |
Why?
| Tissue Scaffolds | 1 | 2011 | 179 | 0.020 |
Why?
| Piperazines | 1 | 2010 | 310 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2009 | 438 | 0.020 |
Why?
| gamma-Glutamyltransferase | 1 | 1988 | 42 | 0.020 |
Why?
| Vitamin A | 2 | 1986 | 52 | 0.020 |
Why?
| Organoids | 1 | 1988 | 74 | 0.020 |
Why?
| Isoelectric Point | 1 | 1987 | 22 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 1988 | 79 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 787 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 1206 | 0.020 |
Why?
| Interferon-gamma | 1 | 1990 | 719 | 0.020 |
Why?
| Protease Inhibitors | 1 | 1988 | 96 | 0.020 |
Why?
| Body Weight | 1 | 2011 | 868 | 0.020 |
Why?
| Antigens, Ly | 1 | 1987 | 45 | 0.020 |
Why?
| Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| Dimethyl Sulfoxide | 1 | 1987 | 42 | 0.020 |
Why?
| Interleukin-6 | 1 | 1990 | 673 | 0.020 |
Why?
| Occludin | 1 | 2006 | 10 | 0.020 |
Why?
| LIM Domain Proteins | 1 | 2006 | 13 | 0.020 |
Why?
| Claudin-1 | 1 | 2006 | 21 | 0.020 |
Why?
| Immunoassay | 1 | 1987 | 95 | 0.020 |
Why?
| Olfactory Bulb | 1 | 2008 | 123 | 0.020 |
Why?
| Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 4 | 0.020 |
Why?
| Aged | 3 | 2020 | 18973 | 0.020 |
Why?
| Receptors, Steroid | 1 | 2006 | 46 | 0.020 |
Why?
| Chemistry | 1 | 1985 | 38 | 0.020 |
Why?
| Chemical Phenomena | 1 | 1985 | 80 | 0.020 |
Why?
| Fluocinolone Acetonide | 1 | 1985 | 16 | 0.020 |
Why?
| Phosphorylation | 1 | 2009 | 1559 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2012 | 1880 | 0.020 |
Why?
| X-Ray Diffraction | 1 | 1985 | 84 | 0.020 |
Why?
| Young Adult | 1 | 2020 | 10459 | 0.020 |
Why?
| HeLa Cells | 1 | 2007 | 563 | 0.020 |
Why?
| Protein Processing, Post-Translational | 1 | 1987 | 399 | 0.020 |
Why?
| Microscopy, Electron, Scanning | 1 | 1985 | 192 | 0.020 |
Why?
| Calcium-Binding Proteins | 1 | 1986 | 205 | 0.020 |
Why?
| Cattle | 2 | 1988 | 918 | 0.020 |
Why?
| Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 18 | 0.020 |
Why?
| Liver | 1 | 1992 | 1633 | 0.010 |
Why?
| Calcineurin Inhibitors | 1 | 2005 | 58 | 0.010 |
Why?
| YY1 Transcription Factor | 1 | 2004 | 27 | 0.010 |
Why?
| NFATC Transcription Factors | 1 | 2005 | 78 | 0.010 |
Why?
| Adolescent | 2 | 2020 | 17811 | 0.010 |
Why?
| Base Composition | 1 | 1984 | 75 | 0.010 |
Why?
| Hormone Antagonists | 1 | 2004 | 33 | 0.010 |
Why?
| Antibodies, Monoclonal | 2 | 1990 | 1257 | 0.010 |
Why?
| Thymidine | 2 | 1994 | 58 | 0.010 |
Why?
| Antigen-Antibody Complex | 1 | 1984 | 84 | 0.010 |
Why?
| Terminology as Topic | 1 | 1985 | 187 | 0.010 |
Why?
| Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| Extracellular Matrix | 1 | 1987 | 436 | 0.010 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 2004 | 63 | 0.010 |
Why?
| src-Family Kinases | 1 | 2004 | 88 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 926 | 0.010 |
Why?
| Craniofacial Abnormalities | 1 | 2004 | 59 | 0.010 |
Why?
| Interleukin-1 | 1 | 1988 | 965 | 0.010 |
Why?
| Weaning | 1 | 2003 | 48 | 0.010 |
Why?
| Stomach Diseases | 1 | 2003 | 19 | 0.010 |
Why?
| Esophageal Diseases | 1 | 2003 | 24 | 0.010 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2003 | 61 | 0.010 |
Why?
| Mice, Hairless | 2 | 1994 | 74 | 0.010 |
Why?
| Coculture Techniques | 1 | 2003 | 198 | 0.010 |
Why?
| Aging | 1 | 1993 | 1612 | 0.010 |
Why?
| Fibroblast Growth Factors | 1 | 2004 | 162 | 0.010 |
Why?
| Cheek | 2 | 1993 | 16 | 0.010 |
Why?
| RNA, Small Nuclear | 1 | 1981 | 31 | 0.010 |
Why?
| Mice, Inbred A | 1 | 2000 | 45 | 0.010 |
Why?
| Biotransformation | 1 | 2000 | 48 | 0.010 |
Why?
| Risk Factors | 1 | 1994 | 8612 | 0.010 |
Why?
| Peptide Fragments | 1 | 1984 | 665 | 0.010 |
Why?
| Neurons | 1 | 2008 | 1277 | 0.010 |
Why?
| Limb Deformities, Congenital | 1 | 1999 | 8 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 1837 | 0.010 |
Why?
| Sequence Homology | 1 | 1999 | 39 | 0.010 |
Why?
| Phosphorus Radioisotopes | 1 | 1978 | 27 | 0.010 |
Why?
| Globins | 1 | 1978 | 21 | 0.010 |
Why?
| Cholera Toxin | 2 | 1988 | 27 | 0.010 |
Why?
| Reticulocytes | 1 | 1978 | 16 | 0.010 |
Why?
| Polyribosomes | 1 | 1978 | 22 | 0.010 |
Why?
| RNA Polymerase II | 1 | 1981 | 283 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 97 | 0.010 |
Why?
| Antibody Specificity | 2 | 1989 | 175 | 0.010 |
Why?
| DNA Fragmentation | 1 | 1998 | 47 | 0.010 |
Why?
| Isotope Labeling | 1 | 1978 | 67 | 0.010 |
Why?
| Drug Stability | 1 | 1978 | 151 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 310 | 0.010 |
Why?
| Immunologic Techniques | 2 | 1986 | 39 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 383 | 0.010 |
Why?
| Desmogleins | 1 | 1996 | 5 | 0.010 |
Why?
| Receptors, Estrogen | 1 | 1979 | 371 | 0.010 |
Why?
| Desmoplakins | 1 | 1996 | 19 | 0.010 |
Why?
| Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| Activins | 1 | 1995 | 26 | 0.010 |
Why?
| Musculoskeletal Abnormalities | 1 | 1995 | 10 | 0.010 |
Why?
| Vibrissae | 1 | 1995 | 10 | 0.010 |
Why?
| Palate | 1 | 1995 | 28 | 0.010 |
Why?
| Xenopus | 1 | 1995 | 94 | 0.010 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1998 | 615 | 0.010 |
Why?
| Musculoskeletal System | 1 | 1995 | 42 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 1997 | 429 | 0.010 |
Why?
| Estrus | 1 | 1994 | 11 | 0.010 |
Why?
| Lymph Nodes | 1 | 1997 | 415 | 0.010 |
Why?
| Acetone | 1 | 1994 | 10 | 0.010 |
Why?
| Skull | 1 | 1995 | 119 | 0.010 |
Why?
| Dendritic Cells | 1 | 1997 | 435 | 0.010 |
Why?
| Cell Fusion | 1 | 1993 | 50 | 0.010 |
Why?
| Protein Kinase C | 1 | 1994 | 271 | 0.010 |
Why?
| Organelles | 1 | 1991 | 51 | 0.010 |
Why?
| Retroviridae | 1 | 1991 | 89 | 0.010 |
Why?
| Cell Line, Transformed | 1 | 1991 | 133 | 0.010 |
Why?
| Trypsin | 1 | 1990 | 66 | 0.010 |
Why?
| Peptide Mapping | 1 | 1990 | 60 | 0.010 |
Why?
| von Willebrand Factor | 1 | 1990 | 55 | 0.010 |
Why?
| DNA, Recombinant | 2 | 1979 | 41 | 0.000 |
Why?
| RNA Probes | 1 | 1988 | 13 | 0.000 |
Why?
| Autoradiography | 1 | 1988 | 69 | 0.000 |
Why?
| HLA-DR Antigens | 1 | 1990 | 219 | 0.000 |
Why?
| Histocytochemistry | 1 | 1988 | 78 | 0.000 |
Why?
| Metaphase | 1 | 1988 | 28 | 0.000 |
Why?
| Light | 1 | 1990 | 336 | 0.000 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 1988 | 45 | 0.000 |
Why?
| Cytoplasm | 1 | 1988 | 255 | 0.000 |
Why?
| Microbial Collagenase | 1 | 1987 | 10 | 0.000 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 99 | 0.000 |
Why?
| Culture Techniques | 1 | 1987 | 78 | 0.000 |
Why?
| Cross Reactions | 1 | 1988 | 118 | 0.000 |
Why?
| Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 1987 | 33 | 0.000 |
Why?
| Leukemia, Experimental | 1 | 1987 | 27 | 0.000 |
Why?
| Cricetulus | 1 | 1987 | 97 | 0.000 |
Why?
| Inflammation | 1 | 1997 | 2465 | 0.000 |
Why?
| Diterpenes | 1 | 1986 | 31 | 0.000 |
Why?
| Genetic Markers | 1 | 1987 | 320 | 0.000 |
Why?
| Incidence | 1 | 1991 | 2314 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1996 | 6307 | 0.000 |
Why?
| Lipopolysaccharides | 1 | 1988 | 813 | 0.000 |
Why?
| Poly A | 1 | 1982 | 45 | 0.000 |
Why?
| DNA-Directed RNA Polymerases | 1 | 1979 | 51 | 0.000 |
Why?
| Retrospective Studies | 1 | 1991 | 12521 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|